|Born||July 8, 1966
|Fields||virology, influenza, SARS, infectious diseases, HIV, microbiology|
|Institutions||Institut Pasteur of Shanghai
Griffith University of Australia
|Alma mater||State University of New York at Stony Brook
Institut Pasteur, Paris
University of Tübingen
Prof. Dr. Ralf M. Altmeyer is a German virologist who leads the Institut Pasteur of Shanghai, a joint institute of the Chinese Academy of Sciences, Institut Pasteur and Shanghai Municipal Government, founded in 2004.
He completed his pre-doctoral studies at the State University of New York at Stony Brook, and holds a Ph. D. (1994) from Institut Pasteur in Paris, where he also completed his postdoctoral thesis on neuropathogenesis of HIV infections (1996).
During his career of fifteen years at Institut Pasteur and the Pasteur international network, Ralf Altmeyer held various management positions including the position of CEO of the HKU-Pasteur Research Centre in Hong Kong. From 2003 to 2006 Ralf Altmeyer was the architect of a successful restructuring and establishment of the organization’s new strategy.
He left Institut Pasteur in 2006 to become the President of CombinatoRx-Singapore, the infectious disease subsidiary of CombinatoRx (NASDAQ:CRXX), established in 2005 in collaboration with Bio*One Capital in Singapore. Ralf Altmeyer left CombinatoRx-Singapore in summer 2009 subsequent to the acquisition of the company by Forma Therapeutics. In 2011, he founded Advance BioChina, a Shanghai-based incubator company that helps global biotech companies access the Chinese market .
- Official press release on the Chinese Academy of Sciences website - Feb 1, 2010 
- Official statement on the HKU-PRC Research Centre - July 2006
- Speaker list of the BioInvest Asia 2008 Forum
- List of staff at Institute of Glycomics of Griffith University